November 1999 – The CenterWatch Monthly : PDF
The Speed Demons of Drug Development
Based on CenterWatch analysis of more than 725 NCEs approved since 1981, AstraZeneca, GlaxoWellcome and Merck are among the five fastest companies at clinical development.
Fastest companies cite several key factors driving development speed, including more globally-oriented development planning, more substantive communications with regulatory authorities and the use of data management technologies.
Alternative Medicine's Move into Clinical Trials
Consumer sales of alternative medicines have dramatically increased in the past 10 years.
Despite several hurdles, pharmaceutical companies are expected to increase clinical trials of botanicals to gain competitive advantages.
Also in this issue:
- Centre Stage Europe: Profiad Secures Investment for Global Expansion
- Eye On Migraine: 18 Drugs in Research for Migraine